Iain McFadyen

Iain joined Tessera in October 2021 as Chief Data Officer, bringing his experience working across various modalities (including mRNA, proteins, and vaccines) and scientific areas to Tessera’s GENE WRITING™ technology platform and various clinical programs.

Dr. McFadyen has deep technical expertise in genomics, transcriptomics, protein structure analysis to structure-based drug design, chemoinformatics, deep learning, and translational bioinformatics, which he honed during his time as Chief Data Officer at LifeMine Therapeutics and as Vice President of Computational Sciences and Next Generation Analytics at Moderna. During his time at Moderna, Dr. McFadyen founded, built, and led the Computational Sciences department, which included people working in data science, and helped develop the platform that delivered mRNA and lipid nanoparticles to patients in the form of the coronavirus vaccine.

Dr. McFadyen earned his Ph.D. in Pharmacology from Loughborough University (UK) and the University of Michigan in the Traynor Lab, later serving as a Postdoctoral Research Associate at the University of Minnesota. He received his B.S. in Medicinal and

Pharmaceutical Chemistry from Loughborough University. Dr. McFadyen is the author of 21 publications and the inventor on eight patents and patent families with 16 patent applications pending.